세계의 이오파미돌 주사제 시장 : 유형별, 용도별, 국가별, 지역별 - 산업 분석, 시장 규모 및 점유율, 예측(2025-2032년)

REPORT HIGHLIGHT

Iopamidol Injection Market size was valued at US$ 1,591.6 Million in 2024, expanding at a CAGR of 4.50% from 2025 to 2032.

The non-ionic, water-soluble contrast agent iopamidol injection is mostly used in diagnostic imaging tests such as computed tomography (CT) scans. It is required in order to improve the visibility of internal organs and structures, which facilitates precise diagnosis and treatment planning. This diagnostic breakthrough is especially important for musculoskeletal, neurological, and cardiovascular exams. The market is driven by a number of factors, such as the growing incidence of chronic illnesses like neurological and cardiovascular conditions, the growing need for less invasive diagnostic techniques, and developments in imaging technology. The world's population is getting older, which increases demand as age-related illnesses become more common. The creation of low-dose imaging systems and higher requirements for image quality are two examples of recent technological developments that offer substantial prospects for market growth. Despite these advantages, the market is confronted with obstacles that could hinder its expansion, such as strict regulatory requirements and possible adverse effects linked to iodine-based contrast agents. High prices and restricted supply in developing areas also pose limitations. One promising area of research and development is the creation of safer, more affordable agents with fewer side effects and improved efficacy.

Iopamidol Injection Market- Market Dynamics

Rising Prevalence of Chronic Illness

The growing cases of chronic illnesses like cancer, neurological disorders, and cardiovascular disorders is one of the main reasons driving the market for iopamidol injections. In order to accurately diagnose and plan for therapy, many disorders frequently require sophisticated imaging techniques. Its demand is greatly increased by the widespread use of iopamidol, a non-ionic, water-soluble contrast agent, in various imaging modalities, including CT scans, angiography, and myelography. Additional factors driving the market include ongoing developments in imaging technology that improve the precision and effectiveness of diagnostic processes. Moreover, the necessity for diagnostic imaging treatments increases as people age because chronic diseases are more common in older adults. Because they are more vulnerable to diseases like cancer, neurological problems, and cardiovascular ailments, the aged population increases the need for contrast agents like iopamidol. Furthermore, the rise in preventive healthcare practices that follow the increased knowledge of early disease diagnosis is a major factor driving market expansion.

Iopamidol Injection Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.50% over the forecast period (2025-2032)

Based on type segmentation, the 9 g I/30 mL was predicted to show maximum market share in the year 2024

Based on application segmentation, hospitals were the leading application in 2024

On the basis of region, North America was the leading revenue generator in 2024

Iopamidol Injection Market- Segmentation Analysis:

The Global Iopamidol Injection Market is segmented on the basis of Type, application, and Region.

On the basis of type, the market is segregated into two categories: 9 g I/ 30 mL and 11.1 g I/ 30 mL. Due to its extensive use in diagnostic imaging procedures, including computed tomography (CT) scans and angiography, the 9 g I/30 mL category of the iopamidol injection market is expanding significantly. Because of its ideal iodine content, which maximizes imaging contrast while lowering patient risk, this concentration is especially preferred. The adoption of this category has been further fueled by the growing demand for precise and non-invasive diagnostic solutions due to the rising prevalence of chronic diseases, such as cardiovascular and neurological ailments.

Based on application, the market is divided into Hospitals, Clinics, and Others. Due to their extensive array of diagnostic and therapeutic services, hospitals make up the largest category. Iopamidol injections are often used in hospitals because of their high patient volume and sophisticated imaging equipment. This segment's demand for Iopamidol is driven by the growing number of imaging procedures conducted in hospitals and the incidence of chronic disorders. Market expansion is further aided by hospitals' emphasis on offering precise and effective diagnostic services.

Iopamidol Injection Market- Geographical Insights

The market for iopamidol injection is anticipated to expand significantly in the North American area as a result of the rising incidence of chronic illnesses like cancer and cardiovascular diseases that call for diagnostic imaging. The market is expanding in North American region due to the well-established healthcare infrastructure and the high rate of adoption of modern imaging technologies. Additionally, the region's expansion is aided by financing for diagnostic imaging research, supportive government initiatives, and the presence of major market competitors.

The iopamidol injection market in Europe is expected to grow steadily due to an older population and a rise in diagnostic imaging techniques. The market is led by nations like Germany, the United Kingdom, and France because of their sophisticated healthcare systems and high healthcare spending. Further driving market expansion are the incorporation of state-of-the-art imaging technology and the increasing emphasis on non-invasive diagnostic techniques. Strict regulatory frameworks that guarantee the safety and effectiveness of contrast agents like iopamidol also benefit the region, increasing the use of these drugs in diagnostic imaging applications throughout Europe.

Iopamidol Injection Market- Competitive Landscape:

Several major competitors such as GE Healthcare, Bayer AG, Aviceena Pharmaceutical LLC, Sun Pharmaceutical Industries Ltd., Bracco Diagnostics Inc., Sanochemia Pharmazeutika GmbH, and others are actively engaged in R&D, product innovation, and strategic partnerships define the competitive landscape of the Iopamidol Injection market. Businesses are concentrating on growing their product lines, making their products safer and more effective, and boosting their market share through mergers and acquisitions. The competitive landscape is driven by a number of factors, including technological advancements, regulatory clearances, and the ability to adjust to the evolving needs of patients and healthcare providers. To increase their clientele and gain a competitive edge, major industry players are also investing in marketing and distribution strategies.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL IOPAMIDOL INJECTION MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

• GE Healthcare
• Bayer AG
• Aviceena Pharmaceutical LLC
• Sun Pharmaceutical Industries Ltd.
• Bracco Diagnostics Inc.
• Sanochemia Pharmazeutika GmbH
• Guerbet Group
• Jiangsu Hengrui Medicine Co., Ltd.
• Mahe Medical USA, LLC
• Hunan Hansen Pharmaceutical Co., Ltd.
• Taejoon Pharm Co., Ltd.
• Tianjin Pharmaceutical Holdings Co., Ltd.
• Others

GLOBAL IOPAMIDOL INJECTION MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

• 9 g I/ 30 mL
• 11.1 g I/ 30 mL

GLOBAL IOPAMIDOL INJECTION MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

• Hospitals
• Clinics
• Others

GLOBAL IOPAMIDOL INJECTION MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• The Netherlands
• Sweden
• Russia
• Poland
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Thailand
• Philippines
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Iopamidol Injection Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Iopamidol Injection Market Snippet by Type
  • 2.1.2. Iopamidol Injection Market Snippet by Application
  • 2.1.3. Iopamidol Injection Market Snippet by Country
  • 2.1.4. Iopamidol Injection Market Snippet by Region
• 2.2. Competitive Insights

3. Iopamidol Injection Key Market Trends

• 3.1. Iopamidol Injection Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Iopamidol Injection Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Iopamidol Injection Market Opportunities
• 3.4. Iopamidol Injection Market Future Trends

4. Iopamidol Injection Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Iopamidol Injection Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. Iopamidol Injection Market Landscape

• 6.1. Iopamidol Injection Market Share Analysis, 2024
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Iopamidol Injection Market - By Type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
  • 7.1.2. 9 g I/ 30 mL
  • 7.1.3. 11.1 g I/ 30 mL

8. Iopamidol Injection Market - By Application

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
  • 8.1.2. Hospitals
  • 8.1.3. Clinics
  • 8.1.4. Others

9. Iopamidol Injection Market- By Geography

• 9.1. Introduction
  • 9.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
• 9.2. North America
  • 9.2.1. Overview
  • 9.2.2. Iopamidol Injection Key Manufacturers in North America
  • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 9.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.2.6. U.S.
    • 9.2.6.1. Overview
    • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.2.6.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.2.6.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.2.7. Canada
    • 9.2.7.1. Overview
    • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.2.7.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.2.7.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
• 9.3. Europe
  • 9.3.1. Overview
  • 9.3.2. Iopamidol Injection Key Manufacturers in Europe
  • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 9.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.6. Germany
    • 9.3.6.1. Overview
    • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.6.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.6.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.7. France
    • 9.3.7.1. Overview
    • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.7.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.7.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.8. Italy
    • 9.3.8.1. Overview
    • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.9. Spain
    • 9.3.9.1. Overview
    • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.9.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.10. United Kingdom
    • 9.3.10.1. Overview
    • 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.10.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.11. Russia
    • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.12. Netherlands
    • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.13. Sweden
    • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.14. Poland
    • 9.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.15. Rest of Europe
    • 9.3.15.1. Overview
    • 9.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
• 9.4. Asia Pacific (APAC)
  • 9.4.1. Overview
  • 9.4.2. Iopamidol Injection Key Manufacturers in Asia Pacific
  • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 9.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.6. India
    • 9.4.6.1. Overview
    • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.6.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.6.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.7. China
    • 9.4.7.1. Overview
    • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.8. South Korea
    • 9.4.8.1. Overview
    • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.8.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.8.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.9. Japan
    • 9.4.9.1. Overview
    • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.10. Australia
    • 9.4.10.1. Overview
    • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.10.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.10.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.11. Thailand
    • 9.4.11.1. Overview
    • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.11.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.11.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.12. Indonesia
    • 9.4.12.1. Overview
    • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.13. Philippines
    • 9.4.13.1. Overview
    • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.13.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.13.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.14. Rest of APAC
    • 9.4.14.1. Overview
    • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.4.14.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
• 9.5. Latin America
  • 9.5.1. Overview
  • 9.5.2. Iopamidol Injection Key Manufacturers in Latin America
  • 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 9.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5.6. Brazil
    • 9.5.6.1. Overview
    • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.6.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.5.6.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5.7. Mexico
    • 9.5.7.1. Overview
    • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.7.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.5.7.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5.8. Argentina
    • 9.5.8.1. Overview
    • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.8.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.5.8.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5.9. Colombia
    • 9.5.9.1. Overview
    • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.9.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.5.9.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5.10. Rest of LATAM
    • 9.5.10.1. Overview
    • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
• 9.6. Middle East and Africa
  • 9.6.1. Overview
  • 9.6.2. Iopamidol Injection Key Manufacturers in Middle East and Africa
  • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
  • 9.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
  • 9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6.6. Saudi Arabia
    • 9.6.6.1. Overview
    • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6.7. United Arab Emirates
    • 9.6.7.1. Overview
    • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6.8. Israel
    • 9.6.8.1. Overview
    • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.8.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.6.8.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6.9. Turkey
    • 9.6.9.1. Overview
    • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.9.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.6.9.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6.10. Algeria
    • 9.6.10.1. Overview
    • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.10.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.6.10.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6.11. Egypt
    • 9.6.11.1. Overview
    • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.11.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.6.11.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6.12. Rest of MEA
    • 9.6.12.1. Overview
    • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
    • 9.6.12.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Iopamidol Injection Industry

• 10.1. Competitive Dashboard
• 10.2. Company Profiles
  • 10.2.1. GE Healthcare
  • 10.2.2. Bayer AG
  • 10.2.3. Aviceena Pharmaceutical LLC
  • 10.2.4. Sun Pharmaceutical Industries Ltd.
  • 10.2.5. Bracco Diagnostics Inc.
  • 10.2.6. Sanochemia Pharmazeutika GmbH
  • 10.2.7. Guerbet Group
  • 10.2.8. Jiangsu Hengrui Medicine Co., Ltd.
  • 10.2.9. Mahe Medical USA, LLC
  • 10.2.10. Hunan Hansen Pharmaceutical Co., Ltd.
  • 10.2.11. Taejoon Pharm Co., Ltd.
  • 10.2.12. Tianjin Pharmaceutical Holdings Co., Ltd.
  • 10.2.13. Others

11. 360 Degree Analyst View

12. Appendix

• 12.1. Research Methodology
• 12.2. References
• 12.3. Abbreviations
• 12.4. Disclaimer
• 12.5. Contact Us